Home › Korean Stocks
Korean Stocks: KOSDAQ Disclosures in English
Short, factual English summaries of selected KOSDAQ company filings, each with a link to the original on DART.
For reference only, not investment advice.This is a factual summary of a company filing. It is not a recommendation to buy, sell or hold any security. Read the original filing on DART before making any decision. Full disclaimer
How we select and write these
- We pick a small number of material filings (large contracts, investments, guarantees, clinical and regulatory events). We do not post every filing.
- Each summary states what was filed, the key figures and one line of neutral context taken from the filing.
- No buy, sell or hold opinions, price targets or forecasts.
- We do not cover companies in which our editor has a personal or professional interest. See our editorial policy.
Latest summaries
2026-11-20 · Material management matter (clinical)
Raphas: Korean regulator returns Phase 2b/3 trial application for allergic rhinitis immunotherapy DF19001
Raphas · KOSDAQ 214260
2026-11-20 · Single sales/supply contractQuratis signs USD 1.87m clinical drug supply contract with Access to Advanced Health (UK)
Quratis · KOSDAQ 348080
2026-11-20 · Single sales/supply contractKumyang Green Power signs KRW 230bn electrical and telecom works contract for Wonju AI data centre
Kumyang Green Power · KOSDAQ 282720
2026-11-20 · Acquisition of shares in another companyJeju Semiconductor to invest USD 19.5m for 65% of a new memory back-end (OSAT) company in Vietnam
Jeju Semiconductor · KOSDAQ 080220
2026-11-20 · Debt guarantee for another partyDongjin Semichem extends USD 90m guarantee for Hong Kong subsidiary's JPMorgan cash-pooling facility
Dongjin Semichem · KOSDAQ 005290